AI Revolutionizes Drug Discovery Market by 2032
AI in drug discovery market to skyrocket, reaching USD 11,874.24 million by 2032, with a CAGR of 37.5%.
- Latest
- Trending
AI in drug discovery market to skyrocket, reaching USD 11,874.24 million by 2032, with a CAGR of 37.5%.
Recursion Pharmaceuticals acquires Exscientia to enhance AI drug discovery, potentially saving millions in drug development costs.
Stocks surged as labor market news eases recession fears, boosting Dow, S&P, and Nasdaq. Earnings reports also lifted sentiment.
Novo Nordisk's $4.1B Clayton investment creates 1,000 jobs, boosts local economy, and enhances life science growth in North Carolina.
Roche's Hemlibra braces for fierce competition from Novo Nordisk's mim8, as analysts give mixed ratings and forecasts on Roche's strategic ...
Arthur A. Levin sells 40K Avidity shares; BofA ups target to $45 as FDA advances myotonic dystrophy treatment. AI-assisted article ...
Researchers have successfully developed a single-dose vaccine that prompts the production of T-cells and "memory" B cells to fight against ...
J&J's net sales reach $85 billion, up 7% from 2022, while Amazon reports profits of $30 billion on net sales ...
Explore the intricate financial dynamics of Phathom Pharmaceuticals Inc in the pharmaceutical industry through its latest financial report analysis. Unlock ...
Discover the financial insights of Dermira, a biopharmaceutical company, and gain a deeper understanding of their stock performance and market ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.